This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Choongwae Pharma Corporation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Mikyoung Hahn: Innovator in Orally Disintegrating Dosage Forms
Introduction
Mikyoung Hahn is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of dosage forms that enhance patient compliance.
Latest Patents
Hahn holds a patent for a composition used in manufacturing orally disintegrating dosage forms. This invention focuses on a method that masks bitter or unpleasant tastes, making medications more palatable. The composition includes a specific ratio of excipients and a coated active substance, which prevents the destruction of the coating layer during the manufacturing process.
Career Highlights
Mikyoung Hahn is associated with Choongwae Pharma Corporation, where he applies his expertise in pharmaceutical innovations. His work has been instrumental in advancing the development of effective and user-friendly medication forms.
Collaborations
Hahn collaborates with talented colleagues, including Jin-Woo Choi and Dae-Hyeon Kim, who contribute to the innovative projects at Choongwae Pharma Corporation.
Conclusion
Mikyoung Hahn's contributions to the pharmaceutical industry, particularly through his patented innovations, highlight his role as a key inventor in enhancing medication delivery systems. His work continues to impact patient care positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile